3:31 PM
 | 
Mar 16, 2017
 |  BC Extra  |  Financial News

Aerpio raises $40M ahead of planned OTC listing

Aerpio Pharmaceuticals Inc. (Cincinnati, Ohio) raised $40 million in a private placement and completed a reverse merger. President and CEO Joseph Gardner told BioCentury the transactions are part of a stepwise process in which the company...

Read the full 157 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >